New Name, Old Problems: US FDA’s Cell And Gene Therapy Office Still Facing Growth Challenges

 
• By Derrick Gingery
Team reorganization
The OTAT renaming and reorganization will allow more flexibility for future growth. • Source: Shutterstock

More from Cell & Gene Therapies

More from Advanced Technologies